| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |